Virpax Pharmaceuticals, Inc. (VRPX)
OTCMKTS · Delayed Price · Currency is USD
0.0060
+0.0049 (445.45%)
Apr 7, 2026, 4:00 PM EST
Virpax Pharmaceuticals Market Cap
Virpax Pharmaceuticals has a market cap or net worth of $7.46 thousand as of April 8, 2026. Its market cap has decreased by -99.78% in one year.
Market Cap
7.46K
Enterprise Value
-1.51M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.01
Market Cap Chart
Since February 17, 2021, Virpax Pharmaceuticals's market cap has decreased from 32.29M to 7.46K, a decrease of -99.98%. That is a compound annual growth rate of -80.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 7, 2026 | 7.46K | -45.95% |
| Dec 31, 2025 | 13.79K | -99.55% |
| Dec 31, 2024 | 3.07M | -18.06% |
| Dec 29, 2023 | 3.75M | -48.56% |
| Dec 30, 2022 | 7.29M | -81.86% |
| Dec 31, 2021 | 40.18M | 24.44% |
| Feb 17, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Comera Life Sciences Holdings | 3.07K |
| OncoVista Innovative Therapies | 2.36K |
| Evelo Biosciences | 1.90K |
| ZIM Corporation | 1.63K |
| DNAPrint Genomics | 1.30K |
| GlobeStar Therapeutics | 1.24K |
| Adhera Therapeutics | 1.16K |
| eFFECTOR Therapeutics | 941.00 |